|
1
|
Gourdie RG, Dimmeler S and Kohl P: Novel
therapeutic strategies targeting fibroblasts and fibrosis in heart
disease. Nat Rev Drug Discov. 15:620–638. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kong P, Christia P and Frangogiannis NG:
The pathogenesis of cardiac fibrosis. Cell Mol Life Sci.
71:549–574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Talman V and Ruskoaho H: Cardiac fibrosis
in myocardial infarction-from repair and remodeling to
regeneration. Cell Tissue Res. 365:563–581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo Y, Gupte M, Umbarkar P, Singh AP, Sui
JY, Force T and Lal H: Entanglement of GSK-3β, β-catenin and TGF-β1
signaling network to regulate myocardial fibrosis. J Mol Cell
Cardiol. 110:109–120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seeland U, Haeuseler C, Hinrichs R,
Rosenkranz S, Pfitzner T, Scharffetter-Kochanek K and Böhm M:
Myocardial fibrosis in transforming growth factor-beta(1)
(TGF-beta(1)) transgenic mice is associated with inhibition of
interstitial collagenase. Eur J Clin Invest. 32:295–303. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao M, Zheng S, Yang J, Wu Y, Ren Y, Kong
X, Li W and Xuan J: Suppression of TGF-β1/Smad signaling pathway by
sesamin contributes to the attenuation of myocardial fibrosis in
spontaneously hypertensive rats. PLoS One. 10:e01213122015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang W, Wang C, Li L and Sun P: Inhibition
of TGF-β1 might be a novel therapeutic target in the treatment of
cardiac fibrosis. Int J Cardiol. 256:192018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Shao L, Ma A, Guan G, Wang J,
Wang Y and Tian G: Telmisartan delays myocardial fibrosis in rats
with hypertensive left ventricular hypertrophy by TGF-β1/Smad
signal pathway. Hypertens Res. 37:43–49. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pezzolesi MG, Satake E, McDonnell KP,
Major M, Smiles AM and Krolewski AS: Circulating TGF-β1-regulated
miRNAs and the risk of rapid progression to ESRD in type 1
diabetes. Diabetes. 64:3285–3293. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Qiu Y, Shi NW, Zhao JN, Wang YC,
Jiang H and Qian HB: microRNA-21 mediates the TGF-β1-induced
migration of keratinocytes via targeting PTEN. Eur Rev Med
Pharmacol Sci. 20:3748–3759. 2016.PubMed/NCBI
|
|
11
|
Castro NE, Kato M, Park JT and Natarajan
R: Transforming growth factor β1 (TGF-β1) enhances expression of
profibrotic genes through a novel signaling cascade and microRNAs
in renal mesangial cells. J Biol Chem. 289:29001–29013. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Q, Cheng Q, Chen Z, Peng R, Chen R, Ma
Z, Wan X, Liu J, Meng M, Peng Z and Jiang B: MicroRNA-663 inhibits
the proliferation, migration and invasion of glioblastoma cells via
targeting TGF-β1. Oncol Rep. 35:1125–1134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Z, Zhang H, Zhang P, Dong W and He L:
MicroRNA-663 suppresses cell invasion and migration by targeting
transforming growth factor beta 1 in papillary thyroid carcinoma.
Tumuor Biol. 37:7633–7644. 2016. View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu ZY, Zhang GL, Wang MM, Xiong YN and
Cui HQ: MicroRNA-663 targets TGFB1 and regulates lung cancer
proliferation. Asian Pac J Cancer Prev. 12:2819–2823.
2011.PubMed/NCBI
|
|
17
|
Van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill JA and Olson EN:
Dysregulation of microRNAs after myocardial infarction reveals a
role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA.
105:13027–13032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fang L, Ellims AH, Moore XL, White DA,
Taylor AJ, Chin-Dusting J and Dart AM: Circulating microRNAs as
biomarkers for diffuse myocardial fibrosis in patients with
hypertrophic cardiomyopathy. J Transl Med. 13:3142015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Turner NA: Inflammatory and fibrotic
responses of cardiac fibroblasts to myocardial damage associated
molecular patterns (DAMPs). J Mol Cell Cardiol. 94:189–200. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Travers JG, Kamal FA, Robbins J, Yutzey KE
and Blaxall BC: Cardiac fibrosis: The fibroblast awakens. Circ Res.
118:1021–1040. 2016. View Article : Google Scholar : PubMed/NCBI
|
